Takahisa Kyogoku
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.
Journal: Targeted oncology
Published: November 20, 2025
Role of posterosuperior pancreatic lymph nodes in gallbladder cancer: A study using the efficacy index.
Journal: Molecular and clinical oncology
Published: June 03, 2025
A case of spindle and giant cell-type undifferentiated carcinoma of the extrahepatic bile duct.
Journal: Clinical journal of gastroenterology
Published: August 15, 2023
A case of progressive xanthogranulomatous pancreatitis with splenic abscess.
Journal: Clinical journal of gastroenterology
Published: August 08, 2023
Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer.
Journal: International journal of clinical oncology
Published: July 23, 2022
Successful En Bloc Resection of Locally Advanced Pancreatic Tail Cancer with Colonic Perforation Following Neoadjuvant Chemotherapy: A Case Report.
Journal: The American journal of case reports
Published: October 15, 2021
Gallbladder cancer spreading into the aberrant cystic duct: First literature report.
Journal: International journal of surgery case reports
Published: September 06, 2021
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
Journal: The oncologist
Published: January 28, 2021
Multicenter analysis of transanal tube placement for prevention of anastomotic leak after low anterior resection.
Journal: Journal of surgical oncology
Published: March 18, 2017
A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer.
Journal: Annals of surgical oncology
Published: September 12, 2016
Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer.
Journal: OncoTargets and therapy
Published: July 29, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026